GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Haemonetics Corporation
Haemonetics is a manufacturer of medical equipment for collecting and processing blood and plasma. Its share price reflects demand for plasma therapy and automated blood bank systems, making its business relatively stable and growing.
Share prices of companies in the market segment - Therapeutic medical equipment
Haemonetics is a medical equipment company and a leader in plasma collection and processing technologies. We classify it as a member of the Therapeutic Medical Equipment sector, and the chart below reflects the dynamics of the entire blood-related medical technology industry.
Broad Market Index - GURU.Markets
Haemonetics is a global healthcare company that provides solutions for the collection and processing of blood and plasma. Its key role in this field makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Haemonetics fits into the overall market dynamics.
Change in the price of a company, segment, and market as a whole per day
HAE - Daily change in the company's share price Haemonetics Corporation
The daily price change of Haemonetics, a manufacturer of blood and plasma collection equipment, reflects the state of the healthcare sector. Change_co measures volatility related to plasma demand and innovations in medical technology. This indicator is an important component of complex formulas on System.GURU.Markets that analyze the medical equipment sector.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
Haemonetics Corporation is a company in the medical device sector. This chart shows the average daily volatility of the MedTech industry. Comparing it to HAE, which focuses on plasma and blood technologies, helps assess whether its niche business is more or less volatile than the sector.
Daily change in the price of a broad market stock, index - GURU.Markets
Haemonetics is a manufacturer of medical equipment and consumables for collecting and processing blood and plasma. The chart below shows overall volatility in the healthcare sector, allowing one to assess how Haemonetics fits within the broader trends.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Haemonetics Corporation
Haemonetics is a leader in blood and plasma collection and processing technologies. Its year-over-year growth reflects the steady demand for its products from donor centers and hospitals. The chart below tells the story of this resilient medical business.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
Haemonetics Corporation is a global healthcare company specializing in blood and plasma collection and processing technologies. Its dominant position in this market ensures stable growth. The chart shows how its innovations and key role in the plasma supply chain influence its "protective" momentum.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Haemonetics, a manufacturer of blood collection and processing equipment, operates in the protective healthcare sector. Demand for its products is stable and driven by medical needs, not the state of the economy. The company's stock performance reflects its success in innovation and sales, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Haemonetics Corporation
Haemonetics, a manufacturer of blood collection and processing equipment, has monthly fluctuations reflecting plasma collection volumes, which depend on donor activity, and hospital demand for its surgical products, providing stable yet cyclical revenue.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
Haemonetics produces medical equipment and consumables for the collection and processing of blood and plasma. Demand for the company's products is stable and supported by the needs of the healthcare system. The medical equipment sector performance chart shows general investment trends in the industry, allowing one to assess Haemonetics' market position and innovative potential.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Haemonetics is a company that produces equipment for collecting and processing blood and plasma. It is a stable business in the healthcare sector. Compared to market fluctuations, as shown in the chart, Haemonetics' performance is typically more stable. Demand for its products is driven by the needs of donor centers and hospitals, not the state of the economy.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Haemonetics Corporation
The shares of Haemonetics, a manufacturer of blood and plasma collection equipment, reflect trends in the healthcare sector. Weekly price movements depend on plasma collection volumes and demand for medical procedures using their technology. The chart below shows how short-term changes in medical practice affect the company's valuation.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
How does Haemonetics' performance compare to the overall medical equipment market? This chart compares the blood collection equipment manufacturer's weekly stock price movements with the sector average. This helps us understand whether its response to plasma and blood component demand is typical, or whether its niche leadership is creating a unique trajectory.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Haemonetics produces medical equipment for collecting and processing blood and plasma. This chart compares its weekly performance to the market. It helps understand whether its business, which involves vital medical procedures, provides price stability and protection from general economic downturns.
Market capitalization of the company, segment and market as a whole
HAE - Market capitalization of the company Haemonetics Corporation
Haemonetics Corporation's market capitalization reflects its leadership in the niche market of blood and plasma collection and processing equipment. The company's value depends on the demand for blood components from hospitals and pharmaceutical companies. The chart shows how investors assess the stability and growth potential of this important healthcare segment.
HAE - Share of the company's market capitalization Haemonetics Corporation within the market segment - Therapeutic medical equipment
Haemonetics Corporation is a global company providing medical technologies for the collection and processing of plasma and blood. Its share of its sector market capitalization reflects its leadership in this important healthcare niche. The chart shows how investors assess the demand for its equipment from blood centers and plasma-based drug manufacturers.
Market capitalization of the market segment - Therapeutic medical equipment
The chart shows the combined market capitalization of blood collection and processing equipment manufacturers. Haemonetics Corporation is a leader in this field. The graph illustrates the scale and stability of the market, which ensures the safety and effectiveness of blood donation and transfusion medicine.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of blood and plasma collection technologies. Haemonetics' market capitalization is determined by the value of its automated systems used in donor centers and hospitals. The line shows the economic value of equipment that ensures the safety and effectiveness of transfusion medicine.
Book value capitalization of the company, segment and market as a whole
HAE - Book value capitalization of the company Haemonetics Corporation
This is an assessment of the assets of Haemonetics Corporation, a manufacturer of medical equipment for blood collection and processing. The chart reflects the value of its plants, which produce plasmapheresis machines and surgical systems, as well as its patents. The growth of this line indicates investments in technologies for blood services and hospitals.
HAE - Share of the company's book capitalization Haemonetics Corporation within the market segment - Therapeutic medical equipment
Haemonetics' physical infrastructure consists of factories producing equipment and consumables for collecting and processing plasma and blood. The chart shows the company's share of production capacity in this critical medical niche, reflecting its role in securing the global supply of blood components.
Market segment balance sheet capitalization - Therapeutic medical equipment
Haemonetics is a leader in blood collection and processing technologies. Its strength lies in its factories, which manufacture sophisticated plasmapheresis machines and other medical devices. This is a capital-intensive business. The chart below illustrates how dependent the entire blood medical device industry is on investment in advanced manufacturing facilities.
Book value of all companies included in the broad market index - GURU.Markets
Haemonetics' assets include factories producing equipment and consumables for collecting and processing blood and plasma. Its book value reflects its leadership in technologies that make blood donations and surgical procedures safer and more effective. The chart shows its weight in the medical industry.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Haemonetics Corporation
Haemonetics produces equipment for collecting and processing blood and plasma. Its balance sheet consists of factories and equipment, but its core value lies in its technology and dominant position in the plasma market. The chart shows the premium it earns for its critical role in the supply chain for producing life-saving plasma-derived medications.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. The company combines manufacturing capabilities with proprietary technologies. The chart shows how the market assesses its technological leadership and market share in the medical technology niche.
Market to book capitalization ratio for the market as a whole
Haemonetics Corporation supplies medical devices and technologies related to blood and plasma, such as plasma collection machines. The chart shows how the market values ββthe leader in its medical niche. The premium its market capitalization has to its assets reflects the value of its patented technologies and long-term contracts with plasma collection centers.
Debts of the company, segment and market as a whole
HAE - Company debts Haemonetics Corporation
Haemonetics supplies medical technologies and equipment related to blood and plasma to hospitals and plasma collection centers. The company's debt load may reflect its investments in developing new equipment or strategic acquisitions to strengthen its position in the medical technology market, as illustrated by this chart.
Market segment debts - Therapeutic medical equipment
Haemonetics supplies innovative medical technologies for the plasma and blood markets. Their equipment is used in blood collection centers and hospitals. This chart illustrates the financial norms for the medical technology sector, where companies must continually invest in R&D to create more effective and safe products, often requiring significant capital.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Haemonetics Corporation
Haemonetics supplies blood and plasma-related medical devices and technologies to hospitals and blood collection centers. The company's growth is fueled by innovation and acquisitions. This chart shows how Haemonetics funds its strategic initiatives and how M&A transactions impact its debt load and financial profile.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
Haemonetics Corporation produces medical equipment for collecting and processing blood and its components. This chart compares the company's debt used for hematology innovation to the overall market capitalization of the entire therapeutic device sector. It helps assess how the company finances its technological leadership in the plasma and blood market.
Debt to book value of all companies in the market
Haemonetics Corporation is a leader in blood processing technologies. This chart compares its debt to the overall book value of the economy. It helps assess how innovation in this important field of medicine is financed and how the company's strategy compares to the overall health care market.
P/E of the company, segment and market as a whole
P/E - Haemonetics Corporation
This chart shows the valuation of Haemonetics Corporation, a manufacturer of medical equipment for collecting and processing blood and plasma. The metric reflects investor confidence in the stability of demand for its technology from blood banks and plasma centers. It is an indicator of the health of this important healthcare sector.
P/E of the market segment - Therapeutic medical equipment
This chart shows the average valuation for the medical device industry, in which Haemonetics operates. In this stable and innovative industry, this metric serves as a benchmark for overall growth expectations. Comparisons with this metric help determine whether investors perceive Haemonetics to stand out from its peers.
P/E of the market as a whole
Haemonetics supplies innovative medical technologies for the plasma and blood markets. The company's equipment and software help collect plasma and manage blood supplies in hospitals. This chart, reflecting overall sentiment, provides an insight into investor sentiment toward companies creating critical solutions for the healthcare system.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Haemonetics Corporation
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. This chart shows how the market estimates the company's future revenue, which depends on donation volumes and demand for plasma-based products. It assesses stability and growth in an important healthcare segment.
Future (projected) P/E of the market segment - Therapeutic medical equipment
Haemonetics is a global medical technology company specializing in blood and plasma processing products and solutions. The company's equipment is used in blood collection centers, hospitals, and surgical centers. This chart shows average expectations for the medical device sector, helping to assess Haemonetics in the context of healthcare technology developments.
Future (projected) P/E of the market as a whole
Haemonetics Corporation produces medical equipment for collecting and processing blood and plasma. Demand for its products is stable and driven by the needs of blood centers and hospitals. This stability makes Haemonetics' business defensive against the volatility of overall market expectations, as shown in this chart.
Profit of the company, segment and market as a whole
Company profit Haemonetics Corporation
Haemonetics Corporation provides innovative medical technologies for the collection and processing of blood and its components. The company's revenue depends on demand for its equipment and supplies from plasma collection centers and hospitals. This chart shows how the growing demand for plasma-based products and blood management technologies impacts its financial results.
Profit of companies in the market segment - Therapeutic medical equipment
Haemonetics Corporation is a global medical technology company specializing in blood and plasma collection and processing products. This chart shows the profitability of its therapeutic equipment. Demand for its equipment and consumables is stable and growing in line with the need for blood components. Its results reflect the state of the plasma and donation industry.
Overall market profit
Haemonetics Corporation supplies medical technologies for the collection and processing of plasma and blood. Demand for its equipment and consumables is stable, driven by the healthcare system's need for vital blood components. Despite the cyclical fluctuations of the economy, as this chart illustrates, Haemonetics' business demonstrates resilience.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Haemonetics Corporation
Haemonetics Corporation provides innovative medical technologies for blood and plasma banking, as well as surgery. Future profit projections, shown in this chart, depend on demand for its blood component collection equipment and systems for minimizing blood loss during surgery. This graph is an indicator of activity in the blood transfusion and hospital surgery sectors.
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
Haemonetics Corporation is a global healthcare company providing innovative solutions in blood and plasma technology. This chart shows profitability forecasts for the medical device sector. It reflects expectations for plasma collection volumes and demand for blood transfusion technologies in hospitals.
Future (predicted) profit of the market as a whole
Haemonetics Corporation produces medical equipment for collecting and processing blood and plasma. Demand for their products is stable, driven by healthcare needs. However, the overall profit forecast reflected here impacts the financial health of their customersβblood banks and plasma centers. Economic growth ensures stability in the healthcare sector.
P/S of the company, segment and market as a whole
P/S - Haemonetics Corporation
Haemonetics Corporation produces medical equipment for collecting and processing blood and plasma. The company's revenue depends on demand from blood banks and plasma product manufacturers. The P/S ratio reflects how investors view its technological leadership in this important healthcare niche.
P/S market segment - Therapeutic medical equipment
Haemonetics Corporation provides innovative medical technologies for blood banks and hospitals. Their products are used for collecting and processing plasma and blood. This chart helps understand how the market evaluates their dominant position in the blood technology niche and the stability of their revenue, which is dependent on the healthcare sector.
P/S of the market as a whole
Haemonetics supplies medical technologies for the collection and processing of blood plasma and blood. The company's revenue depends on donation volumes and the use of its equipment in hospitals and blood centers. This chart illustrates the average revenue estimate, which helps understand how the market values ββthe company's revenue, occupying an important niche in the healthcare system.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Haemonetics Corporation
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. This chart reflects investor expectations for future sales, which depend on hospital demand for blood components and plasma collection volumes for drug production, a steadily growing market.
Future (projected) P/S of the market segment - Therapeutic medical equipment
Haemonetics Corporation provides innovative medical technologies that help customers improve patient care and reduce costs. Its products are used in the collection and processing of blood and plasma. This chart compares Haemonetics' future sales expectations with those of other therapeutic medical device manufacturers, reflecting its role in the healthcare system.
Future (projected) P/S of the market as a whole
Haemonetics produces medical equipment for collecting and processing blood and its components. The company's technologies play a critical role in hematology and transfusion medicine. This chart shows overall investor revenue forecasts, and Haemonetics illustrates how specialized medical technologies that support healthcare systems create a sustainable business.
Sales of the company, segment and market as a whole
Company sales Haemonetics Corporation
Haemonetics Corporation is a global medical technology company specializing in blood and plasma collection and processing products. This chart shows revenue from sales of equipment and consumables for blood banks, plasma centers, and hospitals. Sales growth is driven by donation volumes and surgical procedures.
Sales of companies in the market segment - Therapeutic medical equipment
Haemonetics supplies innovative medical technologies for the plasma and blood markets. This chart breaks down its business into key segments: plasma collection equipment, hospital systems, and blood management services. This allows investors to see which of these areas is driving the company's primary growth.
Overall market sales
Haemonetics Corporation supplies medical technologies and devices for collecting and processing blood and plasma. Demand for its products is stable, as plasma collection for drug production is a critical process. This overall economic outlook does not significantly impact Haemonetics' business, which is driven by healthcare needs.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Haemonetics Corporation
Haemonetics Corporation produces medical equipment for collecting and processing blood and its components. The company's revenue forecast depends on plasma and blood donation volumes, as well as the use of its technologies in hospitals. This chart shows analysts' estimates of demand for plasma products and hematology equipment.
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
Haemonetics Corporation supplies medical devices and technologies related to blood and plasma. This chart shows projected revenue for the entire therapeutic medical device sector. It reflects trends in plasma donation and demand for surgical technologies, key markets for Haemonetics' growth and innovation.
Future (projected) sales of the market as a whole
Haemonetics produces medical equipment for collecting and processing blood and plasma. Demand for its products depends on donation volumes and hospital needs. This general economic outlook indirectly impacts business through healthcare system budgets. During periods of growth, clinics and blood centers may invest more in new, more efficient equipment from Haemonetics.
Marginality of the company, segment and market as a whole
Company marginality Haemonetics Corporation
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. This chart shows how the company monetizes its technologies in healthcare. Its profitability depends on demand from blood centers and hospitals for its automated systems, which improve efficiency and safety.
Market segment marginality - Therapeutic medical equipment
Haemonetics supplies medical technologies and devices for the collection and processing of blood and its components. This metric reflects its strong position in the plasma and blood technology market. Consistently high profitability reflects its leadership in its niche, innovative products, and long-term customer relationships.
Market marginality as a whole
Haemonetics Corporation manufactures medical equipment for collecting and processing blood and its components. Its products are used in blood banks, hospitals, and plasma collection centers. This overall profitability curve has little impact on demand for Haemonetics products, which is driven by healthcare system needs and demographic factors.
Employees in the company, segment and market as a whole
Number of employees in the company Haemonetics Corporation
Haemonetics provides innovative medical technologies for the collection and processing of blood and its components. The company's staff includes development engineers, manufacturing personnel, and a global sales team. This chart reflects the scale of its operations, manufacturing equipment and consumables for blood banks and hospitals.
Share of the company's employees Haemonetics Corporation within the market segment - Therapeutic medical equipment
Haemonetics Corporation is a global medical technology company specializing in blood and plasma collection and processing products. This chart illustrates its key role in healthcare. It reflects the significant share of biomedical engineers and manufacturing specialists who create equipment for blood banks and plasma centers within Haemonetics.
Number of employees in the market segment - Therapeutic medical equipment
Haemonetics Corporation provides innovative medical technologies for blood and plasma banks, as well as for surgical procedures. This chart shows employment in the therapeutic medical equipment sector. The growth in the number of specialists in this field reflects the increasing volumes of plasma collection and the demand for technologies that ensure safety and effectiveness in hematology.
Number of employees in the market as a whole
Haemonetics produces medical equipment for collecting and processing blood and plasma. Its growing staff, from engineers to sales specialists, reflects the healthcare system's growing demand for blood components. This is an example of how technology in medicine not only improves treatment but also creates sustainable jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Haemonetics Corporation (HAE)
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. Their business is based on technology and patents. This graph will show a high figure, reflecting the knowledge-intensive nature of their production. Each employee is backed by significant intellectual property and complex production assets.
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Haemonetics is a medical technology company that dominates the market for plasma collection equipment (for Grifols and others) and other blood-handling technologies. This chart shows the industry average. It helps assess the market premium Haemonetics places on its dominant position in this critical, niche B2B technology.
Market capitalization per employee (in thousands of dollars) for the overall market
Haemonetics produces medical equipment and consumables for collecting and processing blood and plasma. It is a high-tech medical business. This chart reflects how the market values ββthe ability of engineers and scientists to create innovative products that improve the safety and effectiveness of blood transfusions and plasmapheresis procedures.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Haemonetics Corporation (HAE)
Haemonetics is a company that supplies medical technologies for collecting and processing blood plasma, as well as hospital systems (for example, for preserving blood during surgeries). This chart shows how successfully the company sells its equipment and, more importantly, its high-margin consumables, generating profit per employee.
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
Haemonetics is a medical technology company, a leader in plasma collection equipment. This chart shows the benchmark for "Therapeutic Equipment." Average profit per employee in this sector is high. It's a "razor and blade business." The benchmark reflects stable, high-margin revenue from "blades" (single-use consumables) generated by a small R&D staff.
Profit per employee (in thousands of dollars) for the market as a whole
Haemonetics produces medical equipment for collecting and processing blood and plasma. Their devices are used in plasma collection centers and hospitals. It's a niche MedTech company. This graph shows the average market profit per employee. It helps understand how profitable the plasma equipment sector, where Haemonetics operates, is per specialist.
Sales to employees of the company, segment and market as a whole
Sales per company employee Haemonetics Corporation (HAE)
Haemonetics Corporation, a manufacturer of medical equipment for collecting and processing blood and plasma, demonstrates the value of its technologies in this graph. High revenue per employee reflects the value and indispensability of its devices for blood banks and plasma collection centers. The increase in this indicator indicates strong demand for blood components.
Sales per employee in the market segment - Therapeutic medical equipment
Haemonetics is a medical technology company specializing in blood and plasma collection and processing equipment. This critical equipment is crucial for the blood supply chain. This chart shows the average revenue per employee in this segment. It helps assess how effectively Haemonetics' team (R&D, manufacturing) competes in the blood supply technology market.
Sales per employee for the market as a whole
Haemonetics Corporation (HAE) creates medical technologies for blood and plasma processing (e.g., at collection centers). This business requires significant R&D and highly qualified personnel. This indicator shows how effectively the company monetizes its innovations. An upward trend in the graph indicates that sales of their patented equipment are outpacing staff growth.
Short shares by company, segment and market as a whole
Shares shorted by company Haemonetics Corporation (HAE)
Haemonetics Corporation (HAE) produces medical equipment for collecting and processing blood plasma, as well as for surgical use. Their core business is plasma center equipment. This chart highlights concerns about this market. Bears may fear that plasma collection growth will slow or that their customers (plasma collectors) will face pressure.
Shares shorted by market segment - Therapeutic medical equipment
Haemonetics is a leader in plasma collection and processing technologies, which are critical for drug development. This business depends on donation volumes and regulations. This indicator summarizes bearish bets on the medical equipment sector. An increase in short positions may indicate that investors expect stricter regulations for plasma centers or pressure on prices, which affects the entire industry.
Shares shorted by the overall market
Haemonetics (HAE) produces medical equipment for collecting and processing blood plasma, as well as blood management systems for hospitals. This chart shows the overall level of market pessimism. The healthcare sector is considered "defensive." This indicator helps assess how stable investors view HAE's business, which depends on a constant need for plasma, regardless of the economic situation.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Haemonetics Corporation (HAE)
Haemonetics (HAE) is a medical device company specializing in blood and plasma collection and processing technologies. Their equipment is used in hospitals and plasma collection centers. This oscillator chart measures the rate of price change. It helps you see when the stock is overbought (above 70) on strong earnings or oversold (below 30) due to regulatory concerns or a decline in procedures.
RSI 14 Market Segment - Therapeutic medical equipment
Haemonetics (HAE) is a leader in blood processing technologies. They produce plasma collection equipment (their core business) and blood salvage systems for surgeries. This chart tracks overall sentiment in the Therapeutic Equipment sector. It helps understand whether HAE is benefiting from rising plasma demand or whether the entire industry is overheated or oversold.
RSI 14 for the overall market
Haemonetics (HAE) produces equipment for collecting and managing blood plasma in hospitals. This chart shows that its business is "defensive." Demand for plasma for medical purposes is not affected by euphoria or panic. In times of panic, investors often seek safe haven in stable healthcare companies like HAE.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast HAE (Haemonetics Corporation)
Haemonetics (HAE) is a medical technology company with leadership in two segments: plasma collection (equipment for Grifols and CSL) and hospital solutions (e.g., hemostasis). This chart shows the average analyst forecast. It reflects their expectations for growth in plasma collection volumes and the adoption of Haemonetics medical devices in hospitals.
The difference between the consensus estimate and the actual stock price HAE (Haemonetics Corporation)
Haemonetics is a medical technology company that dominates the plasma collection and processing equipment market (plasmapheresis). Their devices are the basis for Grifols and CSL. This chart shows the upside and downside potential of the stock according to analysts. It measures the gap between the consensus price forecast and the current price, reflecting confidence in the plasma market.
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
Haemonetics is a leader in blood transfusion technology. The company produces equipment that collects and separates blood components (plasma, platelets) from donors. This chart shows general expectations for the therapeutic equipment sector. It reflects whether experts believe the blood products market will grow.
Analysts' consensus forecast for the overall market share price
Haemonetics (HAE) is a blood company. They are leaders in plasmapheresis (plasma collection equipment) and hospital technologies (blood analyzers). This graph, reflecting expert expectations, affects their clients (Grifols, CSL). In a downturn (pessimism), plasma collectors may slow down the opening of new centers (HAE equipment).
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Haemonetics Corporation
Haemonetics is a dominant company in the plasma niche. They produce automated equipment (Apheresis) used to collect blood plasma (their core business) and platelets. This chart is an indicator of plasma collection. It likely aggregates plasma collection volumes in the US (their clients include Grifols and CSL) and the growth of their other, smaller hospital businesses.
AKIMA Market Segment Index - Therapeutic medical equipment
Haemonetics (HAE) is a leader in blood technology, dominating two niches: plasma collection equipment (for Grifols) and hospital blood management systems (TEG). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does HAE's dual (plasma + hospital) model differentiate it from the average medtech competitor?
The AKIM Index for the overall market
Haemonetics is blood. The company is a leader in plasma collection and processing equipment (for Grifols, CSL) and hospital technologies (autotransfusion). This chart, reflecting the market average, is a backdrop. It helps assess how this defensive (non-cyclical) MedTech business stacks up against the backdrop of general macroeconomic fluctuations.